Anal Fistula
Conditions
Interventions
Control group:The Jingwanhong ointment used in the control group was a commonly used clinical medication for anal fistula (provided by Tianjin Darentang Jingwanhong Pharmaceutical Co. Ltd. with the na
Treatment group:The Zibai ointment used is an in-house preparation of Fujian University of Traditional Chinese Medicine Affiliated People's Hospital. It is used for dressing changes once a day and int
Sponsors
Wang Jing
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with low simple anal fistulas who meet the aforementioned diagnostic criteria; male patients aged between 18 and 60 years; those who voluntarily participate in the study and have signed an informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion criteria: Patients with chronic constipation or gastrointestinal dysfunction; those with severe cardiovascular and cerebrovascular diseases liver and kidney insufficiency or other major systemic diseases; patients with Crohn's disease ulcerative colitis irritable bowel syndrome and other diseases that have a significant impact on the gut microbiota; individuals with mental illnesses.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL-1ß;VSS Scar Tissue Score;Granulation Tissue Growth Score;CCF-FI score;TNF-a;Safety Indicators;Wexner Anal Function Score;Discharge Score;IL-6;IFN-?;Pain Score;Recurrence Rate;wound healing rate;Anorectal Manometry;Wound Edema Score; | — |
Contacts
Public ContactWang Jing
Department of Proctology I The Affiliated Peoples Hospital of Fujian University of Traditional Chinese Medicine
Outcome results
None listed